Compare Becton Dickinson and Co (BDX) vs VanEck Junior Gold Miners (GDXJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs VanEck Junior Gold Miners — how do they compare? Becton Dickinson and Co trades at $154.29 (market cap $41.51B), while VanEck Junior Gold Miners trades at $96.89. The key difference: Becton Dickinson and Co pays a 2.79% dividend while VanEck Junior Gold Miners pays none. Which is the better fit depends on your goals.
| BDX | GDXJ | |
|---|---|---|
Market Cap | $41.51B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $185.39 | $156.19 |
52-Week Low | $135.49 | $64.22 |
Enterprise Value | $57.97B | — |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
GDXJ (VanEck Junior Gold Miners ETF) trades at $95.40, down 3.55% with a bearish technical signal from moving averages. The fund has underperformed peers in 2026 with double-digit declines while other mining ETFs gained. Technical indicators show neutral oscillators but bearish momentum with key support at $92 and resistance at $97. Recent news highlights concerns about the fund's small-cap exposure and portfolio overlap issues.
The outlook remains challenging given GDXJ's 2026 underperformance and technical bearishness. Investment opportunity exists for contrarian bets on gold miner recovery, but risks include Federal Reserve policy uncertainty, weak small-cap gold miner fundamentals, and continued underperformance versus senior mining peers. The fund's high overlap with larger miners reduces diversification benefits.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →
